[1]马明铭,李 芳,杨 慧,等.噻托溴胺粉雾剂联合非药物康复方案对慢性阻塞性肺疾病患者BODE指数的影响[J].陕西医学杂志,2019,(4):515-517.
 MA Mingming,LI Fang,YANG Hui,et al.Effect of tiotropium bromide powder and nonpharmacological rehabilitation program on BODE index in patients with chronic obstructive pulmonary disease[J].,2019,(4):515-517.
点击复制

噻托溴胺粉雾剂联合非药物康复方案对慢性阻塞性肺疾病患者BODE指数的影响
分享到:

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2019年4期
页码:
515-517
栏目:
药物与临床
出版日期:
2019-04-05

文章信息/Info

Title:
Effect of tiotropium bromide powder and nonpharmacological rehabilitation program on BODE index in patients with chronic obstructive pulmonary disease
文章编号:
DOI: 10.3969/j.issn.10007377.2019.04.031
作者:
马明铭李 芳杨 慧阿选德
西宁市第一人民医院呼吸内科(西宁 810000)
Author(s):
MA MingmingLI FangYANG Huiet al.
Department of Respiratory Medicine Xining No.1 Peoples Hospical(Xining 810000)
关键词:
慢性阻塞性肺疾病噻托溴铵粉雾剂康复方案效果BODE指数对比研究
Keywords:
Key words Chronic obstructive pulmonary disease Tiotropium bromide powder for inhalation Rehabilitation program Effect BODE indexComparative study〖HJ1〗
分类号:
R563
文献标志码:
A
摘要:
摘 要 目的:探讨噻托溴铵粉雾剂联合非药物康复方案治疗慢性阻塞性肺疾病(COPD)患者的临床效果以及对患者BODE指数的影响作用。方法:收治的慢阻肺患者62例作为本次研究的对象随机分为两组,治疗组31例使用噻托溴铵粉雾剂联合康复治疗,对照组31例使用噻托溴铵粉雾剂治疗,观察两组患者的临床疗效。结果:治疗后治疗组临床总有效率为93.55%,明显高于对照组70.97%(P<0.05);治疗前两组患者BODE指数各项指标比较差异无统计学意义(P>0.05),治疗后均明显改善,治疗组改善情况明显优于对照组(P<0.05)。结论:在使用噻托溴铵粉雾剂治疗的基础上联合非药物康复治疗方案能够有效的提高或改善患者的临床治疗效果,提高预后降低病死率。
Abstract:
Abstract Objective:To investigate the clinical effect of Tiotropium Bromide Powder for Inhalation combined with non drug rehabilitation program in the treatment of chronic obstructive pulmonary disease (COPD) and its effect on the BDDE index.Methods:62 patients with chronic obstructive pulmonary disease were randomly divided into two groups. The study group was treated with tiotropium bromide powder combined with rehabilitation therapy. 31 patients in the group were treated with tiotropium bromide powder, and the clinical efficacy of the two groups was observed.Results:After treatment, the total effective rate of the study group was 93.55%, which was significantly higher than that of the control group (70.97%) (P<0.05). There was no significant difference in the BODE index between the two groups before treatment (P>0.05). Significant improvement, the improvement of the study group was significantly better than the control group (P<0.05).Conclusion:The combination of tiotropium bromide powder therapy combined with nonpharmaceutical rehabilitation treatment can effectively improve or improve the clinical treatment effect of patients, improve the prognosis and reduce the mortality rate.

参考文献/References:

[1] 王月霞,莫家赐,成东海,等.太极拳运动对慢性阻塞性肺疾病患者生存质量和BODE指数的影响[J].中国康复医学杂志,2014,29(8):745-747.
[2] 朱迎霞,李海峰,王 玉,等.康复治疗对慢性阻塞性肺疾病稳定期BODE指数及预后的影响[J].昆明医科大学学报,2013,34(1):106-108.
[3] Yin YQ,Zheng HY,Wei J,et al.Effect observation of Tiotropium combined non-invasive ventilation on chronic obstructive pulmonary disease and pulmonary function in patients with type Ⅱ respiratory failure[J].China Modern Medicine,2018, 12(6):216-218.
[4] 杜舒婷,邢 彬,王春霞,等.太极拳运动对慢性阻塞性肺疾病患者BODE指数和SGRQ评分的影响[J].中国运动医学杂志,2013,32(5):403-407.
[5] 王 玲,居来提·赛买提,杜丽娟,等.培土生金法对慢性阻塞性肺疾病患者BODE指数及生活质量的影响[J].中国实验方剂学杂志,2012,18(14):269-272.
[6] Jayaram L,Wong C,Mcauley S,et al.Combined therapy with tiotropium and formoterol in chronic obstructive pulmonary disease:effect on the 6-Minute walk test[J].Copd-journal of Chronic Obstructive Pulmonary Disease,2013,10(4):466-472.
[7] 崔妙玲,赵 琳,李敏燕,等.慢性阻塞性肺疾病患者BODE指数与焦虑抑郁状况的研究进展[J].中国实用护理杂志,2013,29(11):6-8.
[8] 赵新国,黄利华,黄捷晖,等.慢性阻塞性肺疾病患者抑郁和焦虑症状与BODE指数关系的相关性分析[J].中华肺部疾病杂志:电子版,2014,7(5):34-36.
[9] Moberg M,Vestbo J,Martinez G,et al.Validation of the i-BODE index as a predictor of hospitalization and mortality in patients with COPD participating in pulmonary rehabilitation[J].Copd Journal of Chronic Obstructive Pulmonary Disease, 2014,11(4):381-387.
[10] 齐 咏,马 芸,王 凯,等.慢性阻塞性肺疾病患者BODE指数与炎性因子的相关性分析[J].中国综合临床,2013,29(3):255-257.

相似文献/References:

[1]朱小川.血小板/淋巴细胞比值预测慢性阻塞性肺疾病急性加重期〖JZ〗伴有早期肾功能损害临床价值[J].陕西医学杂志,2019,(10):1353.
 ZHU Xiaochuan..Clinical value of platelet/lymphocyte ratio in predicting early renal impairment〖JZ〗 in acute exacerbation of chronic obstructive pulmonary disease[J].,2019,(4):1353.
[2]张军营.吸烟对慢阻肺患者血清S100A8/A9、8异前列腺素F2α、组织蛋白酶S及其它炎症因子表达水平的影响*[J].陕西医学杂志,2019,(11):1426.
[3]焦文妤,尚家璐,李树霞△.慢性阻塞性肺疾病患者血清补体C1q肿瘤坏死因子相关蛋白5与肺功能及炎症反应相关性研究[J].陕西医学杂志,2019,(12):1616.
[4]陈辅萍.慢性阻塞性肺疾病并发感染性肺炎危险因素分析[J].陕西医学杂志,2020,49(1):102.
[5]薛佩妮,冯敏娟△,王惠琴.噻托溴铵粉联合糖皮质激素治疗慢性阻塞性肺疾病疗效及对患者生活质量评分的影响*[J].陕西医学杂志,2020,49(2):216.
 XUE Peini,FENG Minjuan,WANG Huiqin..Efficacy of tiotropium bromide combined with glucocorticoids in the treatment of COPD and its effect on patients' quality of life score[J].,2020,49(4):216.
[6]焦文妤,高爱华△.血清可溶性髓系细胞触发受体-1与临床肺部感染评分在慢性阻塞性肺疾病呼吸机相关性肺炎早期诊断及预后判断中的效能研究[J].陕西医学杂志,2020,49(12):1630.[doi:DOI:10.3969/j.issn.1000-7377.2020.12.024]
 JIAO Wenyu,GAO Aihua..Effectiveness of sTREM-1 and CPIS in early diagnosis and prognosis judgment of ventilator-associated pneumonia in COPD[J].,2020,49(4):1630.[doi:DOI:10.3969/j.issn.1000-7377.2020.12.024]
[7]张卓红,赵拖利.慢性阻塞性肺疾病大鼠血液、支气管灌洗液中水通道蛋白及p-c-Jun-N-末端激酶表达情况实验研究[J].陕西医学杂志,2021,50(7):776.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.002]
 ZHANG Zhuohong,ZHAO Tuoli.Expression of AQP-1 and p-JNK in blood and bronchial lavage fluid of rats with COPD[J].,2021,50(4):776.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.002]
[8]余 刚,张飔雪.慢性阻塞性肺疾病急性加重期患者血清干扰素-γ、甲壳质酶蛋白-40水平及与预后、肺功能相关性分析[J].陕西医学杂志,2021,50(10):1223.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.011]
 YU Gang,ZHANG Sixue.The levels of INF-γ and YKL-40 in patients with AECOPD and their correlation with prognosis and lung function[J].,2021,50(4):1223.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.011]
[9]曾德优,张六一,肖 创,等.慢性阻塞性肺疾病动物模型研究进展[J].陕西医学杂志,2022,51(4):507.[doi:DOI:10.3969/j.issn.1000-7377.2022.04.029]
 ZENG Deyou,ZHANG Liuyi,XIAO Chuang,et al.Research progress on animal models of chronic obstructive pulmonary disease[J].,2022,51(4):507.[doi:DOI:10.3969/j.issn.1000-7377.2022.04.029]
[10]李 瑛,陈张琴.胃食管反流病对慢性阻塞性肺疾病患者生活质量及肺功能的影响[J].陕西医学杂志,2022,51(6):702.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.014]
 LI Ying,CHEN Zhangqin.Effect of gastroesophageal reflux disease on quality of life and pulmonary function in patients with chronic obstructive pulmonary disease[J].,2022,51(4):702.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.014]

更新日期/Last Update: 2019-04-10